Puerariae Radix (PR) is the root of Pueraria lobata, an herb widely used in traditional Chinese medicine and as a food seasoning. Owing to its potential anti-oxidative ability, the effects of PR on the inhibition of breast tumors were investigated in this study using the 7,12-dimethylbenz[a]anthracene (DMBA)-treated rat model. Thirty-two female Sprague-Dawley rats were randomly assigned to one of four different treatment groups, with or without PR and/or DMBA administration. At the age of 177 days, all rats were sacrificed, the number and size of tumors were recorded, and blood and tissue samples were collected for assessment of hematological parameters, redox status, and tumorigenesis-related factors. We found that PR supplementation decreased tumor incidence and WBC count but increased the IgM levels, and significantly altered the redox status, elevated serum TGF-β levels, and reduced serum VEGF-C and ICAM-1 levels. The mechanism by which PR decreased the incidence of DMBA-induced rat breast tumors might include ameliorating immunity, enhancing the antioxidant status, increasing the hepatic excretion of carcinogenic metabolites of DMBA, and influencing the expression of tumorigenesis-related factors.
Puerariae Radix (PR) is the root of Pueraria lobata, an herb widely used in traditional Chinese medicine and food preparation. It is commonly prescribed to relieve fever and dysentery, promote the production of body fluid, facilitate eruption, and lessen stiffness and pain in the nape (College, 1986) . PR contains several isoflavonoids, including puerarin, daidzin, daidzein, and genistein (Chiang et al., 2005) . Recent pharmacological research has demonstrated that puerarin, a major isoflavone glycoside of PR, exhibits a wide range of biological activities including protective effects in ischemic myocardial injury , inflammation , and oxidation (Ma et al., 2014; Wang et al., 2016) . In addition, previous studies have indicated that pretreatment with Pueraria mirifica (another species of Pueraria) decreases breast tumor incidence in vivo (Cherdshewasart et al., 2007) , and that PR isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cell lines (Lin et al., 2009 ). However, the mechanism behind the protective effects of PR against breast tumorigenesis in animal models remains unclear. Investigation of the in vivo effects of PR is therefore warranted.
A previous study indicated that elevated oxidative status arising from the imbalance between reactive oxygen species (ROS) and antioxidant systems played an important role in carcinogenesis (Wu, 2006) , a finding consistent with other studies that observed increased oxidative stress in patients with breast cancer (Yeh et al., 2005 (Yeh et al., , 2006 . ROS are a family of molecules that include highly reactive free oxygen radicals produced in all cells during oxygen metabolism. ROS induce diverse biological responses according to the concentrations at which they are present (Sena & Chandel, 2012) . At low levels, ROS have been recognized as intracellular signal transduction molecules that regulate the post-translational modification of kinases and phosphatases to increase cell proliferation and survival (Lee et al., 2002; Giannoni et al., 2005) . However, excessive ROS production can cause damage to cellular macromolecules such as DNA, proteins, and lipids (Valko et al., 2006) . Cells therefore counteract aberrant ROS production by increasing antioxidant system expression, such as by elevating the glutathione (GSH) levels and antioxidant enzyme activities. In recent years, the antioxidant activities of PR have been demonstrated in various diseases including type 2 diabetes mellitus (Xie & Du, 2011) , chronic lead nephrotoxicity (Wang et al., 2013) , and neurodegenerative disease (Zhu et al., 2015) . However, the effects of PR on oxidative stress in breast tumors are yet to be fully elucidated.
Moreover, various tumorigenesis-related factors such as transforming growth factor beta (TGF-β), vascular endothelial growth factor-C (VEGF-C), and intracellular cell adhesion molecule-1 (ICAM-1) have been shown to participate in tumor growth and dissemination (Roskoski, 2007; Buijs et al., 2011; Kotteas et al., 2014) . de Jong et al., have demonstrated that TGF-β expression levels correlated with angiogenesis and prognosis of breast cancer patients (de Jong et al., 1998) . The VEGF-C and the VEGF receptor 3 autocrine signaling pathway is known to regulate mammary tumor cell survival and proliferation (Varney & Singh, 2015) . Furthermore, higher serum levels of ICAM-1 were observed in patients with breast cancer and lymph node metastases (Rykala et al., 2011) . However, little is known about the ability of PR to modulate these tumorigenesis-related factors.
Therefore, the purpose of this study was to evaluate the effects of PR in vivo on 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in Sprague-Dawley female rats. The use of DMBA to induce mammary tumors represents one of the most widely used models of rat mammary carcinogenesis and is appropriate for the study of mammary tumor initiation and promotion (Mehta, 2000) . Furthermore, variations in oxidative status and the previously described tumorigenesis-related factors were explored after PR treatment.
Materials and Methods

Materials
All chemicals and reagents used in this study were of analytical grade. PR in powdered form was purchased from Sun Ten Pharmaceutical Co., Ltd. (Taiwan). Zoletil ® was obtained from Virbac Laboratories (Carros, France). DMBA, thiobarbituricacid (TBA), 1,1,3,3-tetraethoxypropane (TEP), metaphosphoric acid (MPA), sodium nitrite, sodium nitrate, GSH, and oxidized glutathione (GSSG) were obtained from Sigma (St. Louis, MO, USA). Boric acid was obtained from Mallinckrodt Baker, Inc. (Phillipsburg, NJ, USA). Superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione reductase (GRx) activity was assayed using commercial assay kits (Randox Laboratories, UK). IgM, IgG, TGF-β, ICAM-1, and VEGF-C levels were assayed by enzyme-linked immunosorbent assay (ELISA; IgM and IgG, Immunology Consultants Laboratory, Newberg, OR, USA; TGF-β, Bender Medsystems, Vienna, Austria; and ICAM-1 and VEGF-C, R&D Systems, Minneapolis, MN, USA). Primary antibodies against glutathione S-transferase pi (GST-pi), β-actin, and secondary antibodies (goat anti-rabbit and goat anti-mouse IgG) were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, California, USA).
Animals and Experimental Design
The study was approved by the Institutional Animal Care and Use Committee (IACUC) of Kaohsiung Medical University (approval no. 95152). All experiments were performed in accordance with relevant guidelines and regulations. Thirty-two female Sprague-Dawley rats (age: 45 days; weight: 194±8 g) purchased from BioLasco Co., Ltd. (Taiwan) and housed in stainless steel cages in a controlled environment of a 12 h light and 12 h dark cycle at 25±2 °C. After 1 week of acclimatization, rats were randomly assigned to one of four groups (n = 8 per group): control group (no DMBA or PR treatment), PR + group (treated with PR only), DMBA + group (treated with DMBA only), and DMBA + PR + group (treated with both DMBA and PR). At the age of 52 days, the 16 rats in the DMBA + and DMBA + PR + groups were orally administered DMBA (75 mg/kg body weight) to induce the development of breast tumors while the PR + and the DMBA + PR + groups were supplemented with PR (1.75 g/kg body weight, once per day). The number and size of tumors was recorded, and rats were weighed once per week. At the age of 177 days, all rats were sacrificed after anaesthetization with Zoletil ® and blood, liver, and tumor samples were collected for further analysis. Further, to examine which types of tumor were induced by DMBA, sections of breast tissues from the rats were analyzed using hematoxylin and eosin (H&E) staining.
Sample Collection and Preparation
Fasting blood samples were collected from the tail vein of each rat and aliquoted into two EDTA tubes. A complete blood count (CBC) (XE-2100, Sysmex) and GPx assay was performed on one sample, and plasma was obtained from the other sample by centrifugation and used for malondialdehyde (MDA), nitrite, nitrate, IgM, IgG, TGF-β, ICAM-1, and VEGF-C assays. Following the removal of plasma from the sample, the erythrocytes were washed three times with normal saline and aliquots of washed red blood cells (RBC) were assayed for GSH status, SOD, and GRx.
Assay of MDA Levels
Products of MDA in plasma were estimated by the TBA method (Yeh et al., 2005) . MDA reacts with TBA under acidic conditions to form a complex with maximum absorbance at 532 nm. Plasma samples (150 μL) were mixed with 0.75 mL of 0.05 M HCl and 0.25 mL of 0.67% TBA, and then mixed and boiled in heated water at 95 °C for 30 min. After cooling, products were extracted in 1 mL of 15% methanol in n-butanol and centrifuged at 2500 rpm at 4 °C for 30 min. The absorbance of the supernatant was determined at 532 nm by using a spectrophotometer (Spectronic ® 20 Genesys TM , Thermo Fisher Scientific, Waltham, MA, USA).
GSH and GSSG Assay
GSH and GSSG were assayed according to the method of Yen et al., (Yeh et al., 2005) . One hundred μL of washed RBC was added to 300 μL of ice-cold 5% metaphosphoric acid. To precipitate proteins completely, samples were vortexed and incubated on ice for 10 min. After centrifugation at 12,000 rpm for 10 min at 4 °C, supernatants were filtered through a 0.2 μm filter and diluted fivefold before being injected into a capillary electrophoresis system (P/ACE-MDQ, Beckman Coulter, Fullerton, USA). The analysis was performed at a constant temperature (28 °C) using 300 mM borate running buffer (pH 7.8) and with the UV absorbance detectors set to 200 nm.
Nitrite and Nitrate Assay
Nitrite and nitrate were assayed according to the method of Yen et al., (Yeh et al., 2005) . One hundred μL of plasma was added to 400 μL distilled water and filtered through a 0.2 μm filter before being injected into the capillary electrophoresis system (P/ACE-MDQ, Beckman Coulter). The analysis was performed at a constant temperature (23 °C) using 100 mM borate running buffer (pH 10.0) and with the UV absorbance detectors set to 214 nm. The total nitric oxide (NO) was represented by the sum of the nitrite and nitrate contents for further statistical analysis.
Assay of SOD, GPx, and GRx Activity
SOD, GPx, and GRx activity was measured using commercial assay kits (Ransod, Ransel, and GR kits, respectively) (Randox Laboratories, Antrim, UK). In brief, 25 μL whole blood samples were used for the GPx assay, and 250 μL and 500 μL of packed cells were washed three times with physiologic saline for the SOD and GRx assays. All samples were assayed on an autoanalyzer (Synchron CX 7, Beckman Coulter). The results were expressed as U/g Hb.
IgM, IgG, TGF-β, ICAM-1, and VEGF-C Assays
Serum IgM, IgG, TGF-β, ICAM-1, and VEGF-C levels were assessed by ELISA (Immunology Consultants Laboratory; Bender Medsystems, R&D Systems) according to the manufacturer's instructions.
Western Blot Analysis for GST-pi in Liver and Tumor Tissues
Tissues were homogenized using radioimmunoprecipitation (RIPA) lysis buffer (150 mM NaCl, 50 mM Tris, pH 7.5, 1% Tween 20, 0.5% sodium deoxycholate, and 0.1% SDS) and centrifuged at 13,200 rpm for 25 min at 4 °C. Protein concentrations of the supernatants were measured using an autoanalyzer (Vitros 950 Ortho Clinical Diagnostics, Rochester, NY, USA). Samples with 50 μg total protein were fractionated by 12% SDS-PAGE, transferred to a polyvinylidene difluoride membrane, and blocked with 5% milk in Tris-buffered saline (TBS) for 1 h. Next, the membrane was incubated for 1 h with a primary antibody (anti-GST-pi: 1:500; anti-β-actin: 1:5000) and probed for 1 h with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (for GST-pi) or HRP-conjugated goat anti-mouse IgG (for β-actin). Following extensive washed with TBS containing 0.05% (v/v) Tween 20, reactive bands were developed on film using an enhanced chemiluminescence kit (Millipore, Temecula, CA, USA). The band intensity was quantified by densitometry, and the results were expressed relative to the expression of the constitutively expressed protein β-actin.
Statistical Analysis
All data were presented as mean ± SEM. Statistical analysis was performed by Student's t test and one-way analysis of variance (ANOVA) with a least significant difference (LSD) post-test. P values less than 0.05 were considered statistically significant. All statistical analysis was performed using SPSS v17.0 software (IBM, Armonk, New York, USA).
Results
Effects of PR on Body Weight and Tumorigenesis
The histological examination of DMBA-induced breast lesions and normal breast tissues is shown in Figure 1 . All tumors were malignant, and the malignant breast carcinoma lesions were composed of large cells with hyperchromatic nuclei in a desmoplastic stroma. Regarding the effects of PR on body weight, significant decreases in body weight were observed in the PR + group and DMBA + PR + group compared with that in the control group (p < 0.05). Furthermore, the percentage of tumor incidence was lower in the DMBA + PR + group (37.5%) than in the DMBA + group (100%) (p = 0.011). Although a trend of decreasing tumor multiplicity was observed in the DMBA + PR + group, the difference was not statistically significant (Table 1) .
A B 
Effects of PR on Hematological Parameters
As shown in 
Effects of PR on Antioxidant Status
As shown in Table 3 , SOD activity and GSH/GSSG ratio in the blood, and GSH, GSSG, and T-GSH (total GSH) levels in liver tissue were significantly increased in the PR + group compared with the control group (p < 0.05). Furthermore, SOD and GRx activity, GSH and T-GSH levels, GSH/GSSG blood ratio, and GSSG and T-GSH levels in liver tissue from the DMBA + group were higher than the corresponding values for the control group (p < 0.05). Additionally, lower SOD and GRx activity, lower GSH/GSSG ratio, and higher GSSG levels were observed in blood from the DMBA + PR + group than from the DMBA + group (p < 0.05). However, GSH and T-GSH levels and GSH/GSSG ratios were higher in liver tissues from the DMBA 
Effects of PR on Oxidative Stress and Tumorigenesis-Related Factors
Nitrite levels were significantly decreased in the DMBA + PR + group compared with the DMBA + group (p = 0.04). Similar results were observed for total NO, although the p value was borderline significant (0.058). However, no significant differences in other oxidative stress-related factors were observed among the four groups (Table 4) . For the evaluation of tumorigenesis-related factors, higher levels of VEGF-C were observed in the DMBA + group than in the control group (p < 0.001). However, the levels of VEGF-C were significantly decreased in the DMBA + PR + group compared with the DMBA + group (p < 0.001). Higher levels of TGF-β were observed in the PR + group compared with the control group (p = 0.021), and TGF-β and ICAM-1 levels in the DMBA + PR + group were significantly increased and decreased respectively, compared with the DMBA + group (p < 0.05). 
Effects of PR on Relative GST-pi Protein Expression
The effects of PR on relative GST-pi protein expression were examined by western blot analysis. As shown in Figure 2A , there was no significant difference in liver GST-pi protein expression between the control group and the PR + group. However, GST-pi protein expression significantly decreased in the DMBA + group compared with that in the control group (p = 0.004). Moreover, liver GST-pi protein expression was higher in the DMBA + PR + group than in the DMBA + group (p < 0.001). However, in breast tumor tissue, GST-pi protein expression was not significantly different in the DMBA + PR + group compared with the DMBA + group ( Figure 2B ).
A B Figure 2. Effects of PR on the relative GST-pi protein expression in the liver tissue (A) and breast tumor tissue (B) of the experimental rats
Note. The relative GST-pi protein expression levels were determined by GST-pi/β-actin. PR, Puerariae Radix. a p < 0.01 compared with the control group. b p < 0.01 compared with the DMBA + group.
Discussion
Several recent studies have indicated that traditional herbal medicine has significant effects in cancer treatment as well as prevention (Mafuvadze et al., 2011) , although the detailed mechanism for these effects remains unknown. Although PR isoflavones and their metabolites have previously been shown to modulate the growth of breast cancer in vitro (Lin et al., 2009) , this is the first study to investigate these effects in vivo to the best of our knowledge. The present study showed that the incidence of breast tumors decreased significantly following PR administration in a DMBA-induced breast tumor model. Although the average tumor weight and volume in DMBA rats supplemented with PR were higher than those in rats that did not receive PR, this was attributed to a particularly large tumor outlier in one DMBA rat that received PR. Interestingly, our data also showed that supplementation with PR effectively suppressed body weight gain in rats treated with or without DMBA, which was in agreement with a previous finding that puerarin, the major active component of PR, effectively inhibited body weight gain in rats chronically fed a high-fat diet by improving glucose and insulin intolerance . These results strongly suggest that the potential mechanism behind the anticancer effects of PR might include decreasing obesity, an important risk factor for breast cancer, to reduce the risk of breast cancer formation.
According to Liu et al. and Ma et al. , PR promotes immunity by increasing B-cell antibody production, lymphocyte transformation, and phagocytic rate, for example (Ma et al., 2002; Yunbo et al., 2002) . PR intervention decreased the elevated WBC levels caused by DMBA treatment, an effect that could be explained by the anti-inflammatory activity of PR. Moreover, levels of IgM and IgG were remarkably decreased in DMBA rats compared with control rats, regardless of whether PR was administered or not, although PR treatment elevated IgM levels that were lowered following DMBA treatment. These findings indicate that PR reduced the incidence of breast tumors by increasing antibodies to ameliorate immunity in DMBA rats.
DMBA, a polycyclic aromatic hydrocarbon, requires metabolic activation to trigger its carcinogenicity (Barros et al., 2004) . Among the metabolites of DMBA, trans-3,4-dihydrodiol-1,2-epoxide is a carcinogenic product that jas.ccsenet.org Vol. 9, No. 7; can damage DNA (Wong et al., 1983) . As the process of metabolism is often accompanied by the formation of free radicals (Moselhy & Al mslmani, 2008) , the antioxidant system curbs the damaging effects caused by increased ROS. Regarding the antioxidant status of blood, Ray et al., observed that SOD activity was significantly elevated in breast cancer patients (Ray et al., 2000) . Our previous study also showed that there were remarkably higher SOD and GRx activities in the blood of breast cancer patients (Yeh et al., 2005) . Moreover, Navarro et al. reported that SOD and GRx activities were increased in the blood of tumor-bearing mice compared with non-tumor-bearing controls (Navarro et al., 1999) . In the present study, higher SOD and GRx activities were observed in DMBA rats, although this finding was contrary to that of some previous studies (Pandi et al., 2010; Nandakumar & Balasubramanian, 2012) . The discrepancy between SOD and GRx activities in DMBA rats in this study and the previously published studies (Pandi et al., 2010; Nandakumar & Balasubramanian, 2012) which can explain the activation of gene expression by oxidants through antioxidant responsive elements (AREs) (Rushmore et al., 1991) .
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The GSH system comprises GSH, GSSG, and the related enzymes GPx and GRx, which function together to decompose hydrogen peroxide (H 2 O 2 ) and other organic hydroperoxides (Chiou et al., 2014) . GPx reduces H 2 O 2 while oxidizing GSH, and GSSG is reduced back to GSH by GRx in the presence of NADPH (Yao et al., 2006) . In this study, GSH levels and GSH/GSSG ratio in DMBA rats were higher than those in controls, which might be explained by the higher GRx activities observed in the DMBA group. Thus, in the DMBA rats treated with PR, because of the less harmful environment caused by PR, the relatively lower SOD and GRx activity led to the lower GSH/GSSG ratio and higher GSSG levels. The rat hepatic GSH statuses observed in this study also suggest that PR exerts antioxidant effects, regardless of whether DMBA was administered. These results were consistent with those from previous studies indicating that PR supplementation significantly increased hepatic GSH levels in ethanol-treated rats (Lee, 2004) , lead-treated rats , and DMBA-treated hamsters (Rajasekaran et al., 2015) . Likewise, the phase II detoxification enzyme, GST-pi, was suggested to facilitate the excretion of carcinogenic metabolites in conjugation with GSH. The hepatic GST-pi protein levels of DMBA rats were remarkably decreased in this study and indicated that the excretion of DMBA metabolites was impaired, thus leading to neoplasia as proposed in a previous study (Rajasekaran et al., 2015) . Reduced hepatic GST-pi protein levels were observed in DMBA rats that received PR treatment, which suggested that PR reduced tumorigenesis by elevating the expression of GST-pi protein to increase the excretion of carcinogenic metabolites of DMBA in the liver. However, PR did not affect the GSH status or GST-pi protein levels in breast tumor tissue from DMBA rats. Regarding oxidative stress in groups, our data showed that lower levels of nitrite and total NO were observed in DMBA rats treated with PR compared with untreated DMBA rats, which may partly explain the effects of PR on free radical scavenging activities.
The overexpression of certain tumorigenesis-related factors such as VEGF-C, ICAM-1 and TGF-β has been observed in numerous tumors, indicating that these factors may play important roles in tumor initiation, growth, and development (Roskoski, 2007; Buijs et al., 2011; Kotteas et al., 2014) . VEGF-C regulates angiogenesis, an indispensable mechanism in living organisms that controls proliferation, development, and reproduction in normal tissue as well as cancer tissue. In the present study, PR significantly reduced the elevated levels of VEGF-C in DMBA rats, suggesting that it might inhibit breast tumor formation by downregulating vascular angiogenesis factors in rat DMBA-induced breast tumors. An association between puerarin and VEGF has been reported in several studies, and puerarin has been suggested to suppress the vascularization of ectopic endometrial tissues stimulated by 17β-estradiol (Wang et al., 2011) and to inhibit VEGF expression in retinas of streptozotocin-induced early diabetic rats (Chen et al., 2012a) . Other reports suggest that puerarin may induce therapeutic angiogenesis by increasing VEGF mRNA expression in rats with myocardial infarction (Zhang et al., 2006) . The discrepant effects of PR on VEGF expression may possibly be due to differences in species and disease types. Interestingly, similar results were shown with respect to the effect of PR on ICAM-1 levels. ICAM-1 is a multi-functional transmembrane protein, well known for its importance in stabilizing cell-cell interactions, proliferation, and adhesion (Kotteas et al., 2014) . Previous studies have indicated that the inhibitory effects of puerarin on ICAM-1 expression were found to not only exist in human umbilical vein endothelial cells (Hu et al., 2010) , but also to limit early-stage renal damage in diabetic rats (Pan et al., 2015) . The present study showed that PR decreased the levels of ICAM-1 in DMBA-induced breast tumors in rats, an observation supported by the studies described previously. The effect of PR on TGF-β levels was also investigated in this study. TGF-β production has been linked to numerous disease states (Blobe et al., 2000) . Our data showed that the levels of TGF-β in rats that received PR treatment were significantly increased compared with rats that received no PR treatment, whether control rats or rats treated only with DMBA. However, several reports have indicated that puerarin suppressed TGF-β expression in diabetic rats (She et al., 2014) , mice with myocardial fibrosis (Chen et al., 2012b) , and rats with hepatic fibrosis . The TGF-β pathway has a dual role in both tumor suppression and tumor promotion (Sheen et al., 2013) . Zarzynska reported that in the early stages of breast cancer, TGF-β inhibited epithelial cell cycle progression and promoted apoptosis to suppress tumorigenesis (Zarzynska, 2014) . Therefore, we suggest that PR might suppress tumorigenesis in DMBA-induced breast tumor rats by increasing TGF-β expression.
Conclusions
Taken together, PR supplementation not only promotes immunity, but also decreases the incidence of breast tumors and tumor multiplicity in the DMBA breast cancer rat model. Moreover, PR enhanced the antioxidant status of the DMBA rats by elevating hepatic GSH levels, and reduced tumorigenesis by increasing the excretion of carcinogenic metabolites of DMBA in the liver. The underlying mechanisms behind the inhibitory effects of PR on tumorigenesis may therefore involve the elevation of TGF-β levels and reduction of VEGF-C and ICAM-1 levels, which has been summarized in Figure 3 . Figure 3 . A proposed mechanism for the suppressive effects of PR on the tumorigenesis in the DMBA-induced rats. PR suppressed DMBA-induced tumorigenesis in the rats through the elevated hepatic GSH statuses (including GST-pi protein expression) and the TGF-β levels; reducing the inflammation, VEGF-C and ICAM-1 levels 
